Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initiating large-scale clinical trials.

R I Levy, E J Sondik

    Controlled Clinical Trials
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Initiating large clinical trials requires careful analytical decisions due to extensive resource needs. This paper details the National Heart, Lung, and Blood Institute

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chyloperitoneum in a peritoneal dialysis patient.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Race/ethnicity and the 2000 census: implications for public health.

    American journal of public health·2000
    Same author

    Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

    JAMA·2000
    Same author

    Primordial prevention of cardiovascular disease risk factors: panel summary.

    Preventive medicine·2000
    Same author

    Annual summary of vital statistics: trends in the health of Americans during the 20th century.

    Pediatrics·2000
    Same author

    Geographic Information Systems (GIS) in public health practice in the new millennium.

    Journal of public health management and practice : JPHMP·1999
    Same journal

    On the generation and ownership of alpha in medical studies.

    Controlled clinical trials·2004
    Same journal

    An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

    Controlled clinical trials·2004
    Same journal

    Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

    Controlled clinical trials·2004
    Same journal

    Statistical comparison of random allocation methods in cancer clinical trials.

    Controlled clinical trials·2004
    Same journal

    Analyzing bronchodilation with emphasis on disease type, age and sex.

    Controlled clinical trials·2004
    Same journal

    Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

    Controlled clinical trials·2004
    See all related articles

    Area of Science:

    • Clinical trial management
    • Cardiovascular research
    • Public health policy

    Background:

    • Large-scale clinical trials demand significant resources, necessitating rigorous decision-making processes.
    • Effective initiation and management are crucial for maximizing trial impact on medical practice and future research.

    Purpose of the Study:

    • To outline the decision and management processes for initiating clinical trials at the National Heart, Lung, and Blood Institute (NHLBI).
    • To emphasize the rationale and criteria used by the NHLBI in selecting trials.
    • To illustrate the application of these processes with case examples.

    Main Methods:

    • Review of the NHLBI's established procedures for clinical trial initiation.
    • Analysis of the decision-making framework for resource allocation in large-scale studies.

    Related Experiment Videos

  • Case study examination of two distinct trial proposals: one rejected, one approved and ongoing.

    • Main Results:

    • The NHLBI employs a deliberate, analytical process to evaluate and initiate clinical trials.
    • A trial for mild hypertension drug treatment was rejected based on the Institute's criteria.
    • A trial investigating beta-blocker efficacy post-myocardial infarction is currently underway, demonstrating the application of the process.

    Conclusions:

    • The NHLBI's rigorous decision-making process ensures that initiated clinical trials are well-justified and resource-efficient.
    • The presented examples highlight the critical role of strategic planning in advancing cardiovascular research and patient care.